Recent Research in Therapeutic Potentials of Venoms

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".

Deadline for manuscript submissions: 25 September 2025 | Viewed by 99

Special Issue Editors


E-Mail Website
Guest Editor
1. Laboratory of Immunophysiology of Reproduction, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil
2. Laboratory of Biochemistry and Animal Toxins, Federal University of Uberlândia, Uberlândia 38405318, MG, Brazil
Interests: animal venoms; bioprospecting; biotechnological tools; snake venom; alternative treatments; drug discovery; natural products

E-Mail Website
Guest Editor
Multidisciplinary Institute of Health, Federal University of Bahia, Vitória da Conquista 45032290, BA, Brazil
Interests: snake venoms; antitumoral; bioprospecting; biotechnological tools; snake venom; drug discovery

E-Mail Website
Guest Editor
Immunopathology Lab, Butantan Institute, Butantan Foundation, Sao Paulo, SP, Brazil
Interests: animal toxins; bioprospecting; immunology; vaccines; drug discovery

Special Issue Information

Dear Colleagues,

Venoms consist of a complex mixture of biologically active molecules. Structural and functional studies of these compounds have demonstrated their valuable therapeutic potential and applicability in various contexts, increasing interest in exploring venoms’ molecular complexity in greater depth. Venom toxins possess a wide range of pharmacological domains capable of interacting with different targets with high affinity and selectivity, making them promising tools for drug discovery.

The multifaceted properties of venom toxins have driven the development of venom-derived drugs, currently used clinically to treat various human pathophysiological conditions, such as hypertension, thrombosis, and coagulation disorders. Since the FDA approval of Captopril—a classic example of venom as a valuable source of novel drug components—the field of venom-derived drug development has advanced significantly. Beyond their therapeutic potential and clinical applications, venom toxins have been utilized as diagnostic tools for hemostatic disorders and as biochemical tools to gain insights into cellular mechanisms.

We invite researchers from the scientific community to contribute to this Special Issue by submitting original research articles, reviews, and perspectives exploring the diverse applications of venoms across various fields of knowledge. Venom-derived compounds continue to provide valuable insights and solutions for medical, pharmaceutical, and biotechnological challenges. By bringing together cutting-edge studies on the therapeutic potential of venoms, this Special Issue will foster interdisciplinary collaboration and highlight the latest advancements in both basic and applied research in this field.

Dr. Samuel Teixeira
Dr. Daiana Silva Lopes
Dr. Sarah Natalie Cirilo Gimenes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bioprospecting
  • biotechnological tools
  • snake venom toxins
  • drug discovery
  • natural products
  • pharmacological applications
  • molecular targets of venom toxins
  • toxicology
  • peptide therapeutics
  • venom-based drug delivery

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop